Rankings
▼
Calendar
TLPH
Talphera, Inc.
$18M
Q2 2024 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
-$2M
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.15
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$5M
Free Cash Flow
-$5M
Stock-Based Comp.
$223,000
Balance Sheet
Total Assets
$25M
Total Liabilities
$12M
Stockholders' Equity
$13M
Cash & Equivalents
$13M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$253,000
-100.0%
Gross Profit
-$2M
-$1M
-47.0%
Operating Income
-$4M
-$4M
-7.6%
Net Income
-$4M
-$4M
+12.4%
← FY 2024
All Quarters
Q3 2024 →
TLPH Q2 2024 Earnings — Talphera, Inc. Revenue & Financial Results | Market Cap Arena